ZM, M., LF, L., DV, S., & ER, W. (2025). Adeno-associated virus serotype 9 structural heterogeneity and stability characterized by charge detection mass spectrometry. Molecular therapy. Methods & clinical development, 33(4), 101608. https://doi.org/10.1016/j.omtm.2025.101608
Chicago Style (17th ed.) CitationZM, Miller, Lin LF, Schaffer DV, and Williams ER. "Adeno-associated Virus Serotype 9 Structural Heterogeneity and Stability Characterized by Charge Detection Mass Spectrometry." Molecular Therapy. Methods & Clinical Development 33, no. 4 (2025): 101608. https://doi.org/10.1016/j.omtm.2025.101608.
MLA (9th ed.) CitationZM, Miller, et al. "Adeno-associated Virus Serotype 9 Structural Heterogeneity and Stability Characterized by Charge Detection Mass Spectrometry." Molecular Therapy. Methods & Clinical Development, vol. 33, no. 4, 2025, p. 101608, https://doi.org/10.1016/j.omtm.2025.101608.